Cargando…

LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer

(1) Background: Liver kinase B1 (LKB1) is a tumor suppressor gene involved in cell growth and metabolism. However, its alterations are not routinely assessed for guiding therapy in clinical practice. We assessed LKB1 expression by immunohistochemistry as a potential biomarker. (2) Methods: This bice...

Descripción completa

Detalles Bibliográficos
Autores principales:	Avilés-Salas, Alejandro, Díaz-García, Diego A., Lara-Mejía, Luis, Cardona, Andrés F., Orozco-Morales, Mario, Catalán, Rodrigo, Hernández-Pedro, Norma Y., Rios-Garcia, Eduardo, Ramos-Ramírez, Maritza, Arrieta, Oscar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857995/ https://www.ncbi.nlm.nih.gov/pubmed/36661676 http://dx.doi.org/10.3390/curroncol30010027

Ejemplares similares

Modifying factors of PD‐L1 expression on tumor cells in advanced non‐small‐cell lung cancer
por: Avilés‐Salas, Alejandro, et al.
Publicado: (2022)

Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors
por: Orozco-Morales, Mario, et al.
Publicado: (2021)

RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin
por: Muñoz-Montaño, Wendy, et al.
Publicado: (2021)

Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations
por: Arrieta, Oscar, et al.
Publicado: (2020)

Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy
por: Barrón, Feliciano, et al.
Publicado: (2020)

Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer
por: Arrieta, Oscar, et al.
Publicado: (2020)

CD47-SIRPα Axis as a Biomarker and Therapeutic Target in Cancer: Current Perspectives and Future Challenges in Nonsmall Cell Lung Cancer
por: Catalán, Rodrigo, et al.
Publicado: (2020)

Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells
por: Cruz-Rico, Graciela, et al.
Publicado: (2021)

A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition
por: Barrios-Bernal, Pedro, et al.
Publicado: (2023)

Clinical and pathological characteristics associated with the presence of the IS6110 Mycobacterim tuberculosis transposon in neoplastic cells from non-small cell lung cancer patients
por: Arrieta, Oscar, et al.
Publicado: (2022)

Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer
por: Soberanis Pina, Pamela, et al.
Publicado: (2023)

Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma
por: Arrieta, Oscar, et al.
Publicado: (2021)

Targeted next generation sequencing identified a high frequency genetic mutated profile in wood smoke exposure-related lung adenocarcinoma patients
por: Soca-Chafre, Giovanny, et al.
Publicado: (2018)

Re‐irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index
por: Gutierrez Torres, Salvador, et al.
Publicado: (2022)

Obesity paradox and lung cancer, metformin-based therapeutic opportunity?
por: Barrios-Bernal, Pedro, et al.
Publicado: (2023)

Metformin Enhances TKI-Afatinib Cytotoxic Effect, Causing Downregulation of Glycolysis, Epithelial–Mesenchymal Transition, and EGFR-Signaling Pathway Activation in Lung Cancer Cells
por: Barrios-Bernal, Pedro, et al.
Publicado: (2022)

Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses
por: Barrios-Bernal, Pedro, et al.
Publicado: (2022)

Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer
por: Orozco-Morales, Mario, et al.
Publicado: (2016)

LKB1 tumor suppressor: Therapeutic opportunities knock when LKB1 is inactivated
por: Zhou, Wei, et al.
Publicado: (2014)

SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer
por: Zubiete-Franco, Imanol, et al.
Publicado: (2018)

The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung
por: Conde, Esther, et al.
Publicado: (2010)

LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis
por: Qu, Shuang, et al.
Publicado: (2022)

Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK
por: Sandoval‐Rodriguez, Ana, et al.
Publicado: (2020)

Beyond LKB1 Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment
por: Borzi, Cristina, et al.
Publicado: (2020)

Locoregional control and toxicity after pleurectomy/decortication and intensity‐modulated pleural radiation therapy in patients with malignant pleural mesothelioma
por: Arrieta, Oscar, et al.
Publicado: (2020)

Clinical Impact of the COVID‐19 Pandemic in Mexican Patients with Thoracic Malignancies
por: Arrieta, Oscar, et al.
Publicado: (2021)

Apoptosis and apoptotic pathway in actinic prurigo by immunohistochemistry
por: Cuevas-González, Juan-Carlos, et al.
Publicado: (2016)

Gene-expression profiles in lung adenocarcinomas related to chronic wood smoke or tobacco exposure
por: Ortega-Gómez, Alette, et al.
Publicado: (2016)

LKB1 as the ghostwriter of crypt history
por: Jansen, Marnix, et al.
Publicado: (2011)

AMPK potentiation by LKB1 isoforms
por: Thibert, Chantal, et al.
Publicado: (2015)

LKB1 in transmembrane receptor signaling
por: Okon, Imoh S., et al.
Publicado: (2015)

Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancer
por: Arrieta, Oscar, et al.
Publicado: (2023)

Usefulness of immunohistochemistry in the diagnosis of hepatocolangiocarcinoma
por: Mora Morales, Estephani, et al.
Publicado: (2018)

Somatic LKB1 Mutations Promote Cervical Cancer Progression
por: Wingo, Shana N., et al.
Publicado: (2009)

Role of LKB1 in lung cancer development
por: Makowski, L, et al.
Publicado: (2008)

Lkb1 takes different paths to morphogenesis
por: Short, Ben
Publicado: (2012)

New LKB1 function in the primary cilium
por: Maurin, P, et al.
Publicado: (2015)

Utility of IgG4 immunohistochemistry detection in pemphigus diagnosis
por: García-Lechuga, Maricela, et al.
Publicado: (2022)

Immunohistochemistry
por: HAWES, DEBRA, et al.
Publicado: (2009)

Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer
por: Barbier-Torres, Lucía, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tdip233l7p2epvkcrdlguottqe